Effect of soybean Leci-Vita product on serum lipids and fatty acid composition in patients with elevated serum cholesterol and triglyceride levels

Nutrition Research

Volumn 23, Issue 4, 2003, Pages 465-477

  Medić Ristić, Danijela ^a   Ristić, Vanja ^b   Tepšić, Vesna ^b   Ranić, Marija ^b   Ristić, Gordana ^b   Vrbaški, Snežana ^b   Estelecki, Ilona ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Sojaprotein ^*

Author keywords

Fatty acid; Hyperlipidemia; Lecithin; Serum lipids; Soybean

Indexed keywords

CHOLESTEROL; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LINOLEIC ACID; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE; POLYUNSATURATED FATTY ACID; SOYBEAN PROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; DIET SUPPLEMENTATION; ERYTHROCYTE; ERYTHROCYTE LEVEL; FEMALE; FOLLOW UP; HUMAN; HUMAN EXPERIMENT; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; SOYBEAN; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

GLYCINE MAX;

EID: 0038076211     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0271-5317(02)00558-4     Document Type: Article

References (55)

1. Stamfer MJ, Klauss RM, Ma J, Blanche PJ, Holl LG, Sacks FM, Hennekens CH. A prospective study of triglyceride level, low density lipoprotein particle diameter and risk of myocardial infraction. JAMA 1996;272:882-8.
2. Gardner CD, Fortman SP, Kraus RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 1996;276:875-81.
3. Austin MA. Plasma triglyceride and coronary heart disease. Arterioscler Thromb 1991;11:2-14.
4. Crigui MH, Heis G, Cohn R, Cowan LD, Suchindran CM, Bandiwala S, Kritchevsky S, Jacobs DR, Jr, O'Grande HK, Davis CE. Plasma triglyceride level and mortality for coronary heart disease. N England J Med 1993;328:1220-5.
5. Carroll KK. Review of clinical studies on cholesterol lowering response to soy protein. J Am Diet Assoc 1991;91:820-7.
6. Carroll KK, Kurowska EM. Soy consumption and cholesterol reduction: review of animal and human studies. J Nutr 1995;125:594S-7S.
7. Huang YS, Koba K, Horrobin DF, Sugano M. Interrelationship between dietary protein, cholesterol and n-6 polyunsaturated fatty acid metabolism. Prog Lipid Res 1993;32:123-37.
8. Stauffer CE. Refined oils. In: Matthews RH, editor. Legumes: Chemistry, Technology and Human Nutrition. New York: Marcel Dekker, 1989. p. 47-98.
9. Klein BP, Perry AK, Adair N. Incorporating soy proteins into baked products for use in clinical studies. J Nutr 1995;125:666S-74S.
10. Potter SM. Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J Nutr 1995;125:606S-61S.
11. Jimenez MA, Scarino ML, Vignolini F, Mengheri E. Evidence that polyunsaturated lecithin induces a reduction in plasma cholesterol level and favourable changes in lipoprotein composition in hypercholesterolemic rats. J Nutr 1990;120:659-67.
12. Rosseneu BD, Vandamme D, Vercaemst R, Soeteway F, Peeters H, Blaton V. Influence of oral polyunsaturated and saturated phospholipid treatment on the lipid composition and fatty acid profile of chimpanzee lipoproteins. Atherosclerosis 1979;32:141-53.
13. Iwata T, Hoshi S, Takehisa F, Tsutsumi K, Furukawa Y, Kimura SJ. The effect of dietary safflower phospholipid on plasma and liver lipids in rats fed a hypercholesterolemic diet. J Nutr Sci Vitaminol 1992;38:471-9.
14. Ishida T, Koba K, Sugano M, Imaizumi K, Watanabe S, Minoshima R. Cholesterol levels and eicosanoid production in rats fed phosphatidylinositol or soybean lecithin. J Nutr Sci Vitaminol 1988;34(2):237-44.
15. Polichetti E, Diaconesku N, De La Porte PL, Malli L, Portugal H, Pauli AM, Lafont H, Tuchweber B, Youself I, Chanussot F. Cholesterol-lowering effect of soybean lecithin in normolipidaemic rats by stimulation of biliary lipid secretion. Br J Nutr 1996;75(3):471-8.
16. Tompkins RK, Parkin LG. Effects of long-term ingestion of soya phospholipids on serum lipids in human. Am J Surg 1980;140(3):360-4.
17. Sirtori CR, Zucchi-Dentone C, Sirtori M, Gatti E, Descovich GS, Gaddi A, Catin L, Da Col PG, Senin U, Mannarino E. Cholesterol-lowering and HDL-raising properties fo lecithinated soy proteins in type II hyperlipidemic patients. Ann Nutr Metab 1985;29(6):348-57.
18. O'Brien BC, Corrigan SM. Influence of dietary and egg lecithins on lipid responses in cholesterol-fed guinea pigs. Lipids 1988;23(7):647-50.
19. Kurowska EM, Jordan J, Spence JD, Wetmore S, Pichè LA, Radzikowski M, Dandona P, Carroll KK. Effects of substituting dietary soybean protein and oil for milk protein and fat in subjects. Clin Invest Med 1997;20(3):162-70.
20. Cobb M, Turkki P, Linscheer W, Raheja K. Lecithin supplementation in healthy volunteers. Effect on cholesterol esterification and plasma, and bile lipids. Nutr Metab 1980;24:228-37.
21. Greten H, Raetzer H, Stiehl A, Schettler G. The effect of polyunsaturated phospha-tidylcholine on plasma lipids and fecal sterol excretion. Atherosclerosis 1980;36:81-8.
22. Ide T, Murata M. Depressions by dietary phospholipids of soybean and egg yolk origins of hepatic triacylglycerol and fatty acid synthesis in fasted-reefed rats. Ann Nutr Metab 1994;38:340-8.
23. Ghoshal AK, Farber E. Biology of disease. Choline deficiency, lipotrope deficiency and the development of liver disease including liver cancer: A new perspective. Lab Invest 1993;68:255-60.
24. Best CH, Huntsman ME. The effects components of lecithin upon deposition of fat in the liver. J Physical 1932;75:405-12.
25. Ide T, Onto JA. Increased secretion of very low density lipoprotein triglyceride following inhibition of long chain fatty acid oxidation in isolated rat liver. J Biol Chem 1981;256:10247-55.
26. Ide T, Hirabayashi S, Kano S, Sugano M. Soybean phospholipid-dependent reduction in triacylglycerol concentration and synthesis in the liver of fasted-reefed rats. Biochim Biophys Acta 1992;1124:163-70.
27. Murata M, Imaizumi K, Sugano M. Effect of dietary phospholipids and their constituent bases on serum lipid and apolipoproteins in rats. J Nutr 1982;112:1805-8.
28. Imaizumi K, Mawatari K, Murata M, Ikeda I, Sugano M. The contrasting effect of dietary phosphatidylethanolamine and phosphatidylcholine on serum lipoproteins and liver lipids in rats. J Nutr 1983;113:2403-11.
29. Lopes-Virela MF, Stone P, Ellis S, Colwell JA. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 1977;23:882-4.
30. Friedewald WT, Levy RI, Friedrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge. Clin Chem 1972;18:449-502.
31. Mc Namara JR, Cohn JS, Wilson PWF, Schaefer EJ. Calculated values for low density lipoprotein cholesterol in the assessment of lipid abnormalities and coronary disease risk. Clin Chem 1990;36:36-42.
32. Matusik EJ, Reeves VB, Flanagan VP. Determination of fatty acid methyl esters. Analytica Chimica Acta 1984;166:179-88.
33. Harth S, Dreyfus H, Urban PF, Mandel P. Direct thin-layer chromatography of gangliosides of total lipid extracts. Anal Biochem 1978;86:543-51.
34. Anderson J W, Bryan MJ, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. New Engl J Med 1995;333:276-82.
35. Lichtenstein AH. Soy protein, Isoflavones and cardiovascular disease risk. J Nutr 1998;128:1589-92.
36. Fujikawa T. Utilisation of lecithin and practical functions for dietary use. Yukagaku 1991;40:951-8.
37. Ishinaga M, Sugiyama S, Mochizuki T. Daily intakes of fatty acids, sterols and phospholipids by Japanese women and serum cholesterol. J Nutr Sci Vitaminol 1994;40:557-67.
38. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial Results: I. Reduction in incidence on coronary heart disease. JAMA 1984;251:351-64.
39. Carlson LA, Rosenhamer G. Reduction of mortality in the Stockholm Ischemic Heart Disease Primary Prevention Study by combined treatment with clorfibrate and nicotic acid. Acta Med Scand 1988;223:405-18.
40. Summary of second report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of height blood cholesterol in adults. JAMA 1993;269:3015-23.
41. Austin MA, Hokanson JE, Edwards KL. Hypertrigliceridemia as a cardiovascular risk factor. Am J Cardiol 1998;81:7B-12B.
42. Le Blanc MJ, Gavino V, Perea A, Yousef IM, Levy E, Tuchweber B. The role of dietary choline in the beneficial effects of lecithin on the secretion of biliary lipids in rats. Biochim Biophys Acta-Lipids and Lipid Metabolism 1998;1393(2-3):223-34.
43. O'Brien BC, Andrews VG. Influence of dietary egg and soybean phospholipids and triacilglycerol on human serum lipoproteins. Lipids 1993;28:7-12.
44. Gensini GF, Comeglio M, Colella A. Classical risk factors and emerging elements in the risk profile for coronary artery disease. Eur Heart J 1998;19:S53-S61.
45. Wilson TA, Meservey, Nicolosi RJ. Soy lecithin reduces plasma lipoprotein cholesterol and early atherogenesis in hypercholesterolemic monkeys and hamsters: beyond linoleate. Atherosclerosis 1998;140(1):147-53.
46. Lopes SM, Trimbo SL, Mascioli EA, Blackburn GL. Human plasma fatty acid variations and how they related to dietary intake. Am J Clin Nutr 1991;53:628-37.
47. Bjerve KS, Brubakk AM, Fougner KJ, Johnsen H, Midthjell K, Vik T. Omega-3 fatty acids: essential fatty acids with important biological effects and serum phospholipid fatty acids as markers of dietary omega-3 fatty acid intake. Am J Clin Nutr 1993;57:801S-6S.
48. Okita M, Yoshida S, Yamoto J, Suzuki K, Kaneyuki T, Kubota M, Sasagowa T. N-3 and n-6 fatty acid intake and serum phospholipid fatty acid composition in middle-aged, women living in rural and urban areas in Okayama prefecture. J Nutr Sci Vitaminol 1995;41:313-23.
49. Wood A, Buttler S, Riemersma R, Thomson M, Oliver MF, Fulton M, Birtwhistle A, Elton RA. Adipose tissue and platelet fatty acids and coronary heart disease in Schottish men. Lancet 1984;i:117-21.
50. Willis AL. Nutritional and pharmacological factors in eicosonoid biology. Nutr Rev 1981;39:289-300.
51. Wood DA, Butler S, Riemersma RA, Thomson M, Elton RA, MacIntyre C, Oliver MF. Linoleic and eicosapentaenoic acids in adipose tissue and platelets and risk of coronary heart disease. Lancet 1987;i:177-82.
52. Riemersma RA, Wood DA, Butler S, Elton RA, Oliver M, Salo M, Nikkari T, Vartianen E, Puska P, Gey F, Gey F, Rubba P, Mancini M, Fidanza F. Linoleic acid content in adipose tissue and coronary heart disease. Br Med J 1986;292:1423-7.
53. Horrobin DF, Manku MS, Huang YS. Effects of essential fatty acids on prostaglandin biosynthesis. Biomed Biochim Acta 1984;43:S114-S20.
54. Nassar BA, Huang YS, Horrobin DF. Response of tissue phospholipid fatty acid composition to dietary (n-6) and replacement with marine (n-3) and saturated fatty acids in the rat. Nutr Res 1986;6:1397-409.
55. Mills DE, Murphy M, Galley WR. Dietary fatty acids, membrane transport, and oxidative sensitivity in human erythrocytes. Lipids 1995;30:657-63.